letrozole,palbociclib
pfizer,novartis
['letrozole', 'ibrance', 'improve ']
oncologists debate suitability of cdk4/6 inhibitors at asco given long-term ibrance data. seven years of follow-up data showed that ibrance plus letrozole didn't significantly improve survival compared to letrozole alone in advanced er-positive... 